Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd) - EP3636778

The patent EP3636778 was granted to Fred Hutchinson Cancer Center on Jan 12, 2022. The application was originally filed on Aug 18, 2011 under application number EP19190336A. The patent is currently recorded with a legal status of "Revoked".

EP3636778

FRED HUTCHINSON CANCER CENTER
Application Number
EP19190336A
Filing Date
Aug 18, 2011
Status
Revoked
Aug 2, 2024
Grant Date
Jan 12, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CMS CAMERON MCKENNA NABARRO OLSWANGOct 12, 2022CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE
STRAWMANOct 11, 2022MEWBURN ELLISADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONFR19780010975-
DESCRIPTIONEP0707592
DESCRIPTIONUS4376110
OPPOSITIONEP2426203
OPPOSITIONWO2013016352
SEARCHEP2426203
SEARCHUS2009280517
SEARCHWO2005037231
SEARCHWO2013016352
SEARCHWO2013019623

Non-Patent Literature (NPL) Citations (131) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALLO et al., Nat Struct Mol Biol, (20090000), vol. 16, pages 717 - 724-
DESCRIPTION- ALTSCHUL et al., Nucleic Acids Research, (19970000), vol. 25, pages 3389 - 3402-
DESCRIPTION- AUSUBEL et al., Current Protocols in Molecular Biology, Current Protocols Publishing, (19940000), vol. 2-
DESCRIPTION- BELANCIO et al., Semin. Cancer Biol., (20100000), vol. 20, pages 200 - 210-
DESCRIPTION- BOOTH et al., Gene, (20070000), vol. 387, pages 7 - 14-
DESCRIPTION- BOSNAKOVSKI D. et al., PloS One, (20090000), vol. 4, page e8419-
DESCRIPTION- BOSNAKOVSKI et al., Exp Neurol, (20080000), vol. 214, no. 1, pages 87 - 96-
DESCRIPTION- CAO et al., Dev. Cell, (20100000), vol. 18, pages 662 - 674-
DESCRIPTION- CHANG et al., PloS One, (20110000), vol. 6, page e16867-
DESCRIPTION- CLAPP et al., Am. J. Hum. Genet., (20070000), vol. 81, pages 264 - 279-
DESCRIPTION- C. WIJMENGA et al., Nat Genet, (19920000), vol. 2, pages 26 - 30-
DESCRIPTION- D. BOSNAKOVSKI et al., EMBO J., (20080000), vol. 27, pages 2766 - 2779-
DESCRIPTION- DE GREEF et al., Hum. Mutat., (20090000), vol. 30, pages 1449 - 1459-
DESCRIPTION- D. GABELLINI et al., Cell, (20020000), vol. 110, pages 339 - 348-
DESCRIPTION- DU et al., Bioinformatics, (20080000), vol. 24, pages 1547 - 1548-
DESCRIPTION- E. BEAUDOING et al., Genome Res, (20000000), vol. 10, pages 1001 - 1010-
DESCRIPTION- Eur. J. Immunol., (19760000), vol. 6, page 292-
DESCRIPTION- F. AHMED et al., In Silico Biol, (20090000), vol. 9, pages 135 - 148-
DESCRIPTION- FALCONGENTLEMAN, Bioinformatics, (20070000), vol. 23, pages 257 - 258-
DESCRIPTION- FRISULLO et al., J. Clin. Immunol., (20110000), vol. 31, pages 155 - 166-
DESCRIPTION- GABELLINI et al., Nature, (20060000), vol. 439, pages 973 - 977-
DESCRIPTION- GABRIELS et al., Gene, (19990000), vol. 236, pages 25 - 32-
DESCRIPTION- "Genbank", Database accession no. FJ439133-
DESCRIPTION- "GenBank", Database accession no. HM 190191-
DESCRIPTION- GENG et al., Hybridoma (Larchmt, (20110000), vol. 30, no. 2, pages 125 - 130-
DESCRIPTION- GENG et al., Larchmt, (20110000), vol. 30, pages 125 - 130-
DESCRIPTION- H. LIU et al., Bioinformatics, (20050000), vol. 21, pages 671 - 673-
DESCRIPTION- HOLLAND et al., BMC Biol., (20070000), vol. 5, page 47-
DESCRIPTION- J.C. DE GREEF et al., Hum Mutat, (20090000), vol. 30, pages 1449 - 1459-
DESCRIPTION- J.C. DE GREEF et al., Mutat Res, (20080000), vol. 647, pages 94 - 102-
DESCRIPTION- J.C. VAN DEUTEKOM et al., Hum Mol Genet, (19930000), vol. 2, pages 2037 - 2042-
DESCRIPTION- JENSEN et al., Nat. Genet., (19990000), vol. 21, pages 209 - 12-
DESCRIPTION- J. SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, (19890000), vol. 1-3-
DESCRIPTION- KAESSMANN H. et al., Nat Rev Genet, (20090000), vol. 10, pages 19 - 31-
DESCRIPTION- KAWAMURA-SAITO et al., Hum. Mol. Genet., (20060000), vol. 15, pages 2125 - 2137-
DESCRIPTION- KLOOSTER et al., Eur. J. Hum. Genet., (20090000), vol. 17, pages 1615 - 1624-
DESCRIPTION- KNOEPFLER et al., Nucleic Acids Res, (19990000), vol. 27, pages 3752 - 3761-
DESCRIPTION- KOWALJOW et al., Neuromuscul. Discord, (20070000), vol. 17, pages 611 - 623-
DESCRIPTION- KOWALJOW et al., Neuromuscul Disord, (20070000), vol. 17, pages 611 - 623-
DESCRIPTION- KOWALJOW et al., Neuromuscul. Disord., (20070000), vol. 17, pages 611 - 623-
DESCRIPTION- LAOUDJ-CHENIVESSE et al., J. Mol. Med., (20050000), vol. 83, pages 216 - 224-
DESCRIPTION- LEMMERS et al., Am J. Hum Genet, (20040000), vol. 75, pages 1124 - 1130-
DESCRIPTION- LEMMERS et al., Am J Hum Genet, (20070000), vol. 81, pages 884 - 894-
DESCRIPTION- LEMMERS et al., Hum Mol Genet, (19980000), vol. 7, pages 1207 - 1214-
DESCRIPTION- LEMMERS et al., Nat Genet, (20020000), vol. 32, pages 235 - 236-
DESCRIPTION- LEMMERS et al., Science, (20100000), vol. 327, no. 5968, pages 1650 - 1000-
DESCRIPTION- L. SNIDER et al., Hum Mol Genet, (20090000), vol. 75, pages 2414 - 2430-
DESCRIPTION- LYLE et al., Genomics, (19950000), vol. 25, pages 389 - 397-
DESCRIPTION- MAAREL et al., Am J Hum Genet, (20000000), vol. 66, pages 26 - 35-
DESCRIPTION- M. DIXIT et al., PNAS, (20070000), vol. 104, pages 18157 - 18162-
DESCRIPTION- MOLNAR et al., Eur. Arch. Psychiatry Clin. Neuroscie., (19910000), vol. 241, pages 105 - 108-
DESCRIPTION- Monoclonal Antibodies and T-Cell Hybridomas, Elsevier, (19810000), pages 563 - 681-
DESCRIPTION- Nature, (19750000), vol. 256:, page 495-
DESCRIPTION- NELSON et al., Nat Protoc, (20060000), vol. 1, pages 179 - 185-
DESCRIPTION- PALII et al., EMBO J., (20110000), vol. 30, pages 494 - 509-
DESCRIPTION- PARKER H et al., Science, (20090000), vol. 325, pages 995 - 998-
DESCRIPTION- PFAFFL, Nucleic Acids Res, (20010000), vol. 29, page e45-
DESCRIPTION- P.G. VAN OVERVELD et al., Nat Genet, (20030000), vol. 35, pages 315 - 317-
DESCRIPTION- P.S. MASNY et al., Eur J. Hum Genet, (20100000), vol. 75, pages 448 - 456-
DESCRIPTION- REED et al., Exp. Neurol., (20070000), vol. 205, pages 583 - 586-
DESCRIPTION- R.J. LEMMERS et al., Am J. Hum Genet, (20070000), vol. 81, pages 884 - 894-
DESCRIPTION- R.J. LEMMERS et al., Am J. Hum Genet, (20100000), vol. 86, pages 364 - 377-
DESCRIPTION- R. J. LEMMERS et al., Hum. Mol. Genet., (19980000), vol. 7, pages 1207 - 1214-
DESCRIPTION- R. KLOOSTER et al., Eur J. Hum Genet, (20090000), vol. 17, pages 1615 - 1624-
DESCRIPTION- R. KLOOSTER et al., Eur. J. Hum Genet, (20090000), vol. 17, pages 1615 - 1624-
DESCRIPTION- R. TUPLER et al., J Med Genet, (19960000), vol. 33, pages 366 - 370-
DESCRIPTION- SANGER et al., PNAS (USA), (19770000), vol. 74, no. 12, pages 5463 - 5467-
DESCRIPTION- SCHULZ et al., J. Biomed. Biotechnol., (20060000), page 83672-
DESCRIPTION- SIMPSON et al., Nat. Rev. Cancer, (20050000), vol. 5, pages 615 - 625-
DESCRIPTION- SNIDER et al., PloS Genet, (20100000), vol. 6, page eI001181-
DESCRIPTION- TAKAHASHI et al., Cell, (20070000), vol. 131, pages 861 - 872-
DESCRIPTION- TATIANA, A. et al., "Blast 2 Sequences—A New Tool for Comparing Protein and Nucleotide Sequences", FEMS Microbiol. Lett., (19990000), vol. 174, pages 247 - 250-
DESCRIPTION- TAWIL, R. et al., Muscle Nerve, (20060000), vol. 34, pages 1 - 15-
DESCRIPTION- TUPLET et al., J. Med. Genet., (19960000), vol. 33, pages 366 - 370-
DESCRIPTION- VAN OVERVELD et al., Nat. Genet., (20030000), vol. 35, pages 315 - 317-
DESCRIPTION- WALLACE et al., Ann. Neurol., (20110000), vol. 69, pages 540 - 552-
DESCRIPTION- WALLACE et al., Ann Rev. Neurol., (20110000), vol. 69, no. 3, pages 540 - 52-
DESCRIPTION- WATANABE et al., Nature, (20080000), vol. 453, pages 539 - 543-
DESCRIPTION- WETTENHALLSMYTH, Bioinformatics, (20040000), vol. 20, pages 3705 - 3706-
DESCRIPTION- WIJMENGA et al., Nat. Genet., (19920000), vol. 2, pages 26 - 30-
DESCRIPTION- WOOTTON, J.C.S. FEDERHEN, Methods in Enzymology, (19960000), vol. 266, pages 554 - 571-
DESCRIPTION- WUEBBLES et al., Int. J. Clin. Exp. Pathol., (20100000), vol. 3, pages 386 - 400-
DESCRIPTION- WU et al., Duxbl Dev. Dyn., (20100000), vol. 239, pages 927 - 940-
DESCRIPTION- WU S.L. et al., Duxbl Dev Dyn, (20100000), vol. 239, pages 927 - 940-
DESCRIPTION- ZENG, W. et al., PloS Genet, (20090000), vol. 5, page el0000559-
OPPOSITION- ALESSANDRA BELAYEW, "Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace", MDA National Scientific Conference, (20110313), page 8, XP055974299-
OPPOSITION- Mda National Scientific Conference, "Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace. Book of Abstracts", MDA national scientific conference - March 13-16, 2011 Las Vegas Nevada, (20160301), pages 1 - 110, XP055975230-
OPPOSITION- Vanderplanck C, Et Al, "8.: Suppression of DUX4 or DUX4c protein expression by antisense strategies as a therapeutic approachfor FSHD", FSH Society Facioscapulohumeral Muscular Dystrophy [FSHD] 2010 International Research Consortium & Research Planning Meetings, (20101021), pages 1 - 54, XP055975223-
OPPOSITION- WEI et al., "Muscle and connective tissue - antisense and stem cells", Molecular Therapy, (20090000), vol. 17, pages S200 - S201, XP055974296-
OPPOSITION- Lindsay M Wallace; Sara E Garwick; Wenyan Mei; Alexandra Belayew; Frederique Coppee; Katherine J Ladner; Denis Guttridge; Jing Yang; Scott Q Harper, "DUX4 , a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo", Ann Rev Neurol, (20110300), vol. 69, no. 3, pages 540 - 552, XP055075930
OPPOSITION- 7th Australasian Gene Therapy Society Meeting, (20110627), XP055032708
OPPOSITION- 7th Australasian Gene Therapy Society Meeting, Journal of Gene Medicine, (20110627), vol. 13, no. 7-8, pages 410 - 446, XP055162336
OPPOSITION- Anonymous, "055032708", 7th Australasian Gene Therapy Society Meeting, Melbourne, Australia, (20110504), vol. 13, no. 7-8, pages 1 - 7, XP055032708
OPPOSITION- Vanderplanck C; Ansseau E; Charron S; Tassin A; Turki A; Laoudj-Chenivesse D; Wilton S D; Coppée F; Belayew A; Molecular Lab, "Keynote 5: Suppression of DUX4 or DUX4C expression by antisense strategies in a therapeutic approach for FSHD", Journal of Gene D1 Medicine, Melbourne, Australia, (20110504), vol. 13, no. 7-8, page 414, XP055162336
OPPOSITION- RICHARDS et al., Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?, (20110000), pages 325 - 340, XP055214142
OPPOSITION- SAHENK et al., "The Muscular Dystrophies: Distinct Pathogenic Mechanisms Invite Novel Therapeutic Approaches", 2011 Curr Rheumatol Rep Pub, (20110412), XP019901854
OPPOSITION- ARNETT et al., "Therapy for neuromuscular disorders", Current Opinion in Genetics and Development, (20090000), vol. 19, doi:10.1016/j.gde.2009.03.005, pages 290 - 297, XP026171114
OPPOSITION- VAN DER MAAREL et al., "Facioscapulohumeral Muscular Dystrophy and DUX4: Breaking the Silence", Trends Mol Med, (20110000), vol. 17, no. 5, doi:10.1016/j.molmed.2011.01.001, pages 252 - 258, XP028206228
OPPOSITION- Van Der Maarel Silvère M., Tawil Rabi, Tapscott Stephen J., "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence", Trends in Molecular Medicine, (20110000), vol. 17, no. 5, pages 252 - 258, XP028206228
OPPOSITION- DE GREEF et al., "Epigenetic mechanisms of facioscapulohumeral muscular dystrophy", Mutation Research, (20080000), doi:10.1016/j.mrfmmm.2008.07.011, pages 94 - 102, XP025672421
OPPOSITION- Kowaljow; Marcowycz V; Ansseau A; Conde E; Sauvage C B; Matteotti S; Arias C; Corona C; Nunez E D; Leo N G; Wattiez O; Figlewicz R; Laoudj-Chenivesse D; Belayew D; Coppee A; Rosa F; A L, "The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein", Neuromuscul Disord, (20070000), vol. 17, no. 8, pages 611 - 623, XP022145240
OPPOSITION- DMITRIEV et al., "Pearls in the junk: Dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy", Neuromuscular Disorders, (20090000), doi:10.1016/j.nmd.2008.09.004, pages 17 - 20, XP025927854
OPPOSITION- BOSNAKOVSKI et al., "An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies", The EMBO Journal, (20080000), doi:10.1038/emboj.2008.201, pages 2766 - 2779, XP002626056
OPPOSITION- Darko Bosnakovski; Zhaohui Xu; Eun Ji Gang; Cristi L Galindo; Mingju Liu; Tugba Simsek; Harold R Garner; Siamak Agha-Mohammadi; Alexandra Tassin; Frédérique Coppée; Alexandra Belayew; Rita R Perlingeiro; and Michael Kyba, "An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies", EMBO J., (20080000), vol. 27, no. 20, pages 2766 - 2779, XP002626056
OPPOSITION- WALLACE et al., "Developing RNAi Therapy for FSHD", Molecular Therapy, (20090000), vol. 17, doi:10.1038.mt.2009.106, page S151, XP055162326
OPPOSITION- WEI et al., "herapeutic RNAi for Dominant Muscle Disease", Molecular Therapy, (20090000), vol. 17, doi:10.1038.mt.2009.106, page S200, XP055162329
OPPOSITION- Jenny K W Lam, Michael Y T Chow, Yu Zhang, Susan W S Leung, "siRNA Versus miRNA as Therapeutics for Gene Silencing", Molecular Therapy Nucleic Acids, (20150000), vol. 4, no. 9, pages 1 - 20, XP055380675
OPPOSITION- KIM DANIEL H; ROSSI JOHN J, "Strategies for silencing human disease using RNA interference", Nature Reviews Genetics, (20070000), vol. 8, no. 3, pages 173 - 184, XP002520391
OPPOSITION- KIM et al., "Strategies for silencing human disease using RNA interference", Nature Reviews Genetics, (20070000), vol. 8, doi:10.1038/NRG2006, pages 173 - 184, XP002520391
OPPOSITION- DIXIT et al., "DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1", PNAS, (20070000), vol. 104, doi:10.1073/pnas.0708659104, pages 18157 - 18162, XP055075929
OPPOSITION- Dixit Manjusha, Ansseau Eugénie, Tassin Alexandra, Winokur Sara, Shi Rongye, Qian Hong, Sauvage Sébastien, Mattéotti Christel, Van Acker Anne M., Leo Oberdan, Figlewicz Denise, Barro Marietta, Laoudj-Chenivesse Dalila, Belayew Alexandra, Coppée Frédérique, Chen Yi-Wen, "DUX4 , a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1", PNAS, (20070000), vol. 104, pages 18157 - 18162, XP055075929
OPPOSITION- SNIDER et al., "RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy", Human Molecular Genetics, (20090000), vol. 18, no. 13, doi:10.1093/hmg/ddp180, pages 2414 - 2430, XP055091920
OPPOSITION- Snider Lauren, Asawachaicharn Amy, Tyler Ashlee E., Geng Linda N., Petek Lisa M., Maves Lisa, Miller Daniel G., Lemmers Richard J.L.F., Winokur Sara T., Tawil Rabi, Van Der Maarel Silvère M., Filippova Galina N., Tapscott Stephen J., "RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy", Human Molecular Genetics, (20090000), vol. 18, no. 13, pages 2414 - 2430, XP055091920
OPPOSITION- LEMMERS et al., "A Unifying Genetic Model for Facioscapulohumeral Muscular Dystroph y", Science, (20100924), vol. 329, no. 5999, doi:10.1126/science.1189044, pages 1650 - 1653, XP055091773
OPPOSITION- Lemmers Richard J. L. F., Van Der Vliet Patrick J., Klooster Rinse, Sacconi Sabrina, Camaño Pilar, Dauwerse Johannes G., Snider Lauren, Straasheijm Kirsten R., Jan Van Ommen Gert, Padberg George W., Miller Daniel G., Tapscott Stephen J., Tawil Rabi, Frants Rune R., Van Der Maarel Silvère M., "A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy", Science, (20100000), vol. 329, no. 5999, pages 1650 - 1653, XP055091773
OPPOSITION- Richard J L F Lemmers, "Chromosome 10q-linked FSHD identifies DUX4 as principal disease gene", Journal of Medical Genetics, BMJ PUBLISHING GROUP, LONDON, GB, GB , (20220201), vol. 59, no. 2, doi:10.1136/jmedgenet-2020-107041, ISSN 0022-2593, pages 180 - 188, XP093166050
OPPOSITION- BENNETT et al., Annual Review of Pharmacology and Toxicology, vol. 50, (20091019), pages 259 - 293, XP055055378
OPPOSITION- Frank Bennett C; Eric E Swayze, "RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform", Annual Review of Pharmacology and Toxicology, (20091019), vol. 50, pages 259 - 293, XP055055378
OPPOSITION- ZENG et al., "Specific Loss of Histone H3 Lysine 9 Trimethylation and HPlgamma/Cohesin Binding at D4Z4 Repeats Is Associated with Facioscapulohumeral Dystrophy (FSHD", PLoS Genet, (20090000), vol. 5, page l-14, XP055397736
OPPOSITION- SNIDER et al., "Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene", PLOS Genetics, (20101028), vol. 6, no. 10, doi:10.1371/journal.pgen.1001181, XP055011341
OPPOSITION- Snider Lauren, Geng Linda N., Lemmers Richard J. L. F., Kyba Michael, Ware Carol B., Nelson Angelique M., Tawil Rabi, Filippova Galina N., Van Der Maarel Silvère M., Tapscott Stephen J., Miller Daniel G., "Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene", PLoS Genetics, (20100000), vol. 6, no. 10, pages 1 - 14, XP055011341
OPPOSITION- ANSSEAU et al., "DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation", PLoS One., (20090000), vol. 4, no. 10, doi:10.1371/journal.pone.0007482, page e7482, XP055011327
SEARCH- "Human double homeobox 4 (DUX4) mRNA SEQ ID NO:46.", Geneseq, (20120412), Database accession no. AZT86869, URL: EBI, XP002717599 [P] * sequence . *-
SEARCH- C VANDERPLANCK ET AL, "7th Australasian gene therapy society meeting", JOURNAL OF GENE MEDICINE, US, (20110728), vol. 13, no. 7-8, doi:10.1002/jgm.1582, ISSN 1099-498X, pages 410 - 446, XP055373285 [PA] 1-15 * abstract * * the whole document *
SEARCH- VANDERPLANCK C ET AL, "Keynote 5: Suppression of DUX4 or DUX4C expression by antisense strategies in a therapeutic approach for FSHD", JOURNAL OF GENE MEDICINE, US, (20110701), vol. 13, no. 7-8, doi:10.1002/jgm.1582, ISSN 1099-498X, page 414, XP055162336 [PX] 6,8 * the whole document * [Y] 7,9-10
SEARCH- DIXIT M. ET AL, "DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20071107), vol. 104, no. 46, doi:10.1073/pnas.0708659104, ISSN 0027-8424, pages 18157 - 18162, XP055075929 [DA] 1-15 * abstract * * page 18160, column 2, paragraph 3 - page 18161, column 1, paragraph 4 *
SEARCH- S. LAMANDE ET AL, "Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency", HUMAN MOLECULAR GENETICS, (19980601), vol. 7, no. 6, doi:10.1093/hmg/7.6.981, pages 981 - 989, XP055671941 [I] 1,5 * page 985, column 1, paragraph 1 * * figure 6 * * abstract * * the whole document *
SEARCH- SNIDER L ET AL, "RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy", HUMAN MOLECULAR GENETICS, (20090409), vol. 18, no. 13, doi:10.1093/hmg/ddp180, ISSN 0964-6906, pages 2414 - 2430, XP055091920 [A] 1-15 * abstract; figure 7 * * page 2421, column 1, paragraph 2 - column 2, paragraph 1 * * page 2423, column 1, paragraph 2 - page 2424, column 1, paragraph 1 *
SEARCH- SARA MENAZZA ET AL, "Oxidative stres by monoamine oxidases is casually involved in myofiber damage in muscular dystrophy", HUM. MOL. GENET., (20100817), vol. 19, no. 21, doi:10.1093/hmg/ddq339, pages 4207 - 4215, XP055397711 [I] 1-4 * abstract * * the whole document *
SEARCH- LEMMERS R J L F ET AL, "A unifying genetic model for facioscapulohumeral muscular dystrophy", SCIENCE, (20100924), vol. 329, no. 5999, doi:10.1126/science.1189044, ISSN 0036-8075, pages 1650 - 1653, XP055091773 [PY] 7,9-10 * the whole document *
SEARCH- SNIDER L ET AL, "Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene", PLOS GENETICS, (20101028), vol. 6, no. 10, doi:10.1371/journal.pgen.1001181, ISSN 1553-7390, page e1001181, XP055011341 [PY] 7,9-10 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents